| Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
|
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
1.20E-37
|
-6.93E-01
|
-1.87E+00 |
|
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
7.48E-03
|
6.50E-02
|
2.42E-01 |
|
Asthma
|
CA23 |
Nasal and bronchial airway |
1.02E-04
|
1.49E-01
|
1.50E-01 |
|
Behcet's disease
|
4A62 |
Peripheral blood |
6.44E-01
|
1.65E-01
|
6.51E-01 |
|
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
9.24E-02
|
8.71E-02
|
5.92E-01 |
|
Bladder cancer
|
2C94 |
Bladder tissue |
2.21E-03
|
-6.15E-01
|
-2.00E+00 |
|
Breast cancer
|
2C60-2C6Z |
Breast tissue |
5.10E-14
|
-3.23E-01
|
-5.53E-01 |
|
Colon cancer
|
2B90 |
Colon tissue |
1.94E-67
|
-9.59E-01
|
-2.33E+00 |
|
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
3.61E-01
|
7.58E-02
|
7.66E-02 |
|
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
9.10E-01
|
2.10E-02
|
9.20E-02 |
|
Gastric cancer
|
2B72 |
Gastric tissue |
2.04E-01
|
-3.74E-01
|
-1.02E+00 |
|
Glioblastopma
|
2A00.00 |
Nervous tissue |
8.43E-30
|
2.83E-01
|
7.61E-01 |
|
Head and neck cancer
|
2D42 |
Head and neck tissue |
1.37E-03
|
9.01E-02
|
8.87E-02 |
|
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
7.91E-01
|
-6.48E-02
|
-2.45E-01 |
|
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
7.72E-02
|
4.73E-01
|
9.55E-01 |
|
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
1.31E-02
|
-3.47E-01
|
-1.23E+00 |
|
Ischemic stroke
|
8B11 |
Peripheral blood |
4.59E-01
|
1.00E-02
|
4.01E-02 |
|
Liver cancer
|
2C12.0 |
Liver tissue |
5.41E-11
|
-1.50E+00
|
-1.63E+00 |
|
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
2.53E-04
|
-9.67E-01
|
-2.29E+00 |
|
Lung cancer
|
2C25 |
Lung tissue |
4.54E-01
|
-2.09E-02
|
-6.05E-02 |
|
Lupus erythematosus
|
4A40 |
Whole blood |
6.97E-09
|
7.29E-01
|
8.49E-01 |
|
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
8.89E-01
|
-1.17E-02
|
-7.86E-02 |
|
Multiple myeloma
|
2A83.1 |
Bone marrow |
7.10E-03
|
-3.38E-01
|
-1.55E+00 |
|
Multiple myeloma
|
2A83.1 |
Peripheral blood |
9.63E-01
|
-1.24E-02
|
-2.81E-02 |
|
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
5.48E-02
|
-4.65E-01
|
-1.13E+00 |
|
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
7.53E-01
|
3.15E-02
|
6.85E-02 |
|
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
1.28E-02
|
-1.69E-01
|
-2.46E-01 |
|
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
5.84E-02
|
-1.39E-01
|
-6.30E-01 |
|
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
2.85E-01
|
7.58E-02
|
7.99E-02 |
|
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
3.56E-02
|
5.09E-01
|
1.26E+00 |
|
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
3.60E-01
|
6.75E-01
|
9.12E-01 |
|
Oral cancer
|
2B6E |
Oral tissue |
9.23E-05
|
-1.06E+00
|
-1.16E+00 |
|
Ovarian cancer
|
2C73 |
Ovarian tissue |
2.75E-04
|
6.15E-01
|
1.90E+00 |
|
Pancreatic cancer
|
2C10 |
Pancreas |
6.09E-02
|
2.80E-01
|
5.50E-01 |
|
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
8.83E-01
|
9.93E-03
|
2.54E-02 |
|
Pituitary cancer
|
2D12 |
Pituitary tissue |
2.35E-03
|
3.86E-01
|
1.56E+00 |
|
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
9.24E-01
|
3.29E-02
|
2.14E-01 |
|
Pompe disease
|
5C51.3 |
Biceps muscle |
3.46E-01
|
2.82E-01
|
1.10E+00 |
|
Prostate cancer
|
2C82 |
Prostate |
3.30E-02
|
-2.07E-01
|
-2.53E-01 |
|
Psoriasis
|
EA90 |
Skin |
5.91E-05
|
1.23E-01
|
2.71E-01 |
|
Rectal cancer
|
2B92 |
Rectal colon tissue |
3.41E-04
|
-6.86E-01
|
-2.63E+00 |
|
Renal cancer
|
2C90-2C91 |
Kidney |
1.81E-03
|
-6.17E-01
|
-1.42E+00 |
|
Retinoblastoma
|
2D02.2 |
Uvea |
4.55E-05
|
7.68E-01
|
4.00E+00 |
|
Schizophrenia
|
6A20 |
Prefrontal cortex |
8.26E-02
|
1.80E-01
|
2.82E-01 |
|
Schizophrenia
|
6A20 |
Superior temporal cortex |
7.89E-01
|
-1.62E-02
|
-7.49E-02 |
|
Scleroderma
|
4A42.Z |
Whole blood |
2.57E-02
|
-3.53E-01
|
-1.17E+00 |
|
Seizure
|
8A60-8A6Z |
Whole blood |
5.72E-02
|
-1.81E-01
|
-8.01E-01 |
|
Sepsis with septic shock
|
1G41 |
Whole blood |
1.41E-10
|
3.17E-01
|
9.30E-01 |
|
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
5.36E-02
|
-5.09E-01
|
-8.35E-01 |
|
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
2.47E-01
|
-3.94E-01
|
-1.25E+00 |
|
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
2.16E-01
|
1.18E-01
|
6.65E-01 |
|
Skin cancer
|
2C30-2C3Z |
Skin |
4.55E-71
|
-1.48E+00
|
-2.55E+00 |
|
Thrombocythemia
|
3B63 |
Whole blood |
8.04E-02
|
-1.25E-01
|
-7.98E-01 |
|
Thrombocytopenia
|
3B64 |
Whole blood |
3.19E-01
|
6.45E-01
|
8.82E-01 |
|
Thyroid cancer
|
2D10 |
Thyroid |
1.90E-02
|
2.41E-01
|
7.14E-01 |
|
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
3.36E-05
|
1.04E+00
|
1.80E+00 |
|
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
9.49E-01
|
-1.62E-01
|
-7.29E-01 |
|
Type 2 diabetes
|
5A11 |
Liver tissue |
8.80E-01
|
-8.06E-02
|
-2.00E-01 |
|
Ureter cancer
|
2C92 |
Urothelium |
3.51E-01
|
-1.32E-01
|
-3.85E-01 |
|
Uterine cancer
|
2C78 |
Endometrium tissue |
1.26E-01
|
2.78E-01
|
3.28E-01 |
|
Vitiligo
|
ED63.0 |
Skin |
2.14E-01
|
-1.23E-01
|
-4.28E-01 |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
